{
    "2020-05-21": [
        [
            {
                "time": "2020-07-15",
                "original_text": "Fmr. CDC Official: 'we’re not cutting any corners' on COVID-19 vaccine development",
                "features": {
                    "keywords": [
                        "CDC",
                        "vaccine",
                        "development",
                        "corners",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-15",
                "original_text": "For Moderna, a Coronavirus Vaccine Would Be the ‘Tip of the Iceberg’",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Coronavirus",
                        "Vaccine",
                        "Iceberg"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-15",
                "original_text": "AstraZeneca/Merck's Lynparza Get FDA Nod for Prostate Cancer",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Merck",
                        "Lynparza",
                        "FDA",
                        "Prostate",
                        "Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}